About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Cough Suppressant may Help to Block Dyskinesias in Parkinson's Patients

by VR Sreeraman on November 9, 2007 at 1:10 PM
Font : A-A+

Cough Suppressant may Help to Block Dyskinesias in Parkinson's Patients

A study has found a cough suppressant and a drug tested as a schizophrenia therapy help curb disabling side effects of levodopa, a Parkinson's disease medication.

The mouse model based study, led by Melanie A. Paquette, Ph.D., postdoctoral fellow in the Department of Behavioural Neuroscience, OHSU School of Medicine, and the PVAMC, found that Dextromethorphan, used in such cold and flu medications as Robitussin, Sucrets, Triaminic and Vicks, suppressed dyskinesias in rats.

Advertisement

The researchers also found that BMY-14802, a drug previously tested in people with schizophrenia and found to be safe, although not effective in treating schizophrenia symptoms, suppressed dyskinesias in rats more effectively than dextromethorphan did, suggesting that BMY-14802 might work to block dyskinesias in people with Parkinson's.

Dyskinesias are the spastic or repetitive motions that result from taking levodopa, or L-dopa, over long periods. "These results were unexpected, but very exciting. We have filed a patent for the use of BMY-14802 for dyskinesias and we hope to get funding to begin human trials very soon," Paquette said.
Advertisement

The findings also stated the value of the rat model for dyskinesias that was used in the study. Previous studies have shown that the drug amantadine was effective in treating dyskinesias in both humans and rats. "Basically, these two drugs work to block dyskinesias in both humans and rats, and that means the rats are a good model to screen potential drug treatments for humans with dyskinesias," Paquette said.

But BMY-14802, which is an antagonist at sigma-1 receptor sites in the brain, "worked much better than dextromethorphan," an antagonist at N-methyl-D-aspartate (NMDA) receptors. "There's something special about BMY-14802. The effect on dyskinesias is really striking and I've repeated it several times, so it's a reliable finding. It's a very exciting result," Paquette said.

Source: ANI
LIN/C
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Flu Cough Symptom Evaluation Nutritional Management of Parkinsons disease Coughing up Blood Symptom Evaluation 

Recommended Reading
Parkinsons Disease
Parkinson's disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. ...
Nicotine Reduces Dyskinesias in Patients With Parkinsonís
The Parkinson's Institute and Clinical Center today announced the results of research showing that ....
Over-the-counter Pain Drugs may Reduce Parkinson's Disease Risk
A study has found that over-the-counter pain medications known as NSAIDs might help reduce risk of ....
Cough Symptom Evaluation
Cough is a symptom of a condition usually affecting the respiratory tract. It may be acute or chroni...
Coughing up Blood Symptom Evaluation
Coughing up blood in anyone can be alarming. But it is not always serious. However, when there is re...
Nutritional Management of Parkinsons disease
Parkinson's disease is a brain disorder which leads to many other related effects. Nutrition plays a...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use